Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1985-07-02
1987-07-21
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
544346, 546 69, A61K 31495, C07D51902
Patent
active
046818804
ABSTRACT:
9-thia ergot cyclic peptide alkaloids produced by fermentation or synthetic methods have interesting anti-parkinson and other pharmacological activities.
REFERENCES:
patent: 4542135 (1985-09-01), Kobel
Baumert, et al., "Incorporation of Thiazolidine-4-Carboxylic Acid into Erosine . . . ," Chem. Abst. 96: 213,910(r) (1982).
Bolliger Georg
Kobel Hans
Sanglier Jean-Jacques
Tscherter Hans
Daus Donald G.
Hendricks G.
Honor Robert S.
McGovern Thomas O.
Sandoz Ltd.
LandOfFree
Use of thio isosteres of ergot peptide alkaloids as vasaconstric does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of thio isosteres of ergot peptide alkaloids as vasaconstric, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of thio isosteres of ergot peptide alkaloids as vasaconstric will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-207532